Evidence map›Paper›PMID 39473788›Full record

ArticleRSC advances2024

Sol-gel derived ceramic nanocomposite CNFs anchored with a nanostructured CeO

Ahmed Z Alanazi, Khalid Alhazzani, Mohamed M El-Wekil, Al-Montaser Bellah H Ali, Mahmoud Darweesh, Hossieny Ibrahim

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ahmed Z AlanaziDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University Riyadh Saudi Arabia.ORCID https://orcid.org/0000-0002-2937-540X
Khalid AlhazzaniDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University Riyadh Saudi Arabia.ORCID https://orcid.org/0000-0002-1890-1291
Mohamed M El-WekilDepartment of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Assiut University Assiut Egypt.ORCID https://orcid.org/0000-0002-1097-1148
Al-Montaser Bellah H AliDepartment of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Assiut University Assiut Egypt.ORCID https://orcid.org/0009-0003-2631-6038
Mahmoud DarweeshDepartment of Medical Biochemistry and Microbiology, Uppsala University Uppsala Sweden.
Hossieny IbrahimDepartment of Chemistry, Faculty of Science, Assiut University Assiut 71516 Egypt Hossieny.Ibrahim@aun.edu.eg.ORCID https://orcid.org/0000-0001-9008-3564

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the current study, the potential interaction mechanisms between capmatinib (CAP), a selective tyrosine kinase inhibitor, and calf thymus double-stranded DNA (ds-DNA) were evaluated. In this research, we construct an amplified electrochemical platform based on a disposable pencil graphite electrode (PGE) modified with nanostructured CeO

Identifiers

PMID39473788
PMCPMC11520322

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.